Simris Alg AB (publ) (SIMRIS-B) - Cash Flow Conversion Efficiency

Latest as of March 2026: -0.723x

Based on the latest financial reports, Simris Alg AB (publ) (SIMRIS-B) has a cash flow conversion efficiency ratio of -0.723x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-3.97 Million ≈ $-426.91K USD) by net assets (Skr5.49 Million ≈ $590.38K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Simris Alg AB (publ) balance sheet independence to measure how much of total assets are equity-financed.

Simris Alg AB (publ) - Cash Flow Conversion Efficiency Trend (2014–2025)

This chart illustrates how Simris Alg AB (publ)'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Simris Alg AB (publ) total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.

Simris Alg AB (publ) Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Simris Alg AB (publ) ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
SenzaGen AB
ST:SENZA
-0.052x
Climeon AB (publ)
ST:CLIME-B
-0.070x
Leeuwin Metals Ltd
AU:LM1
-0.042x
Securemetric Berhad
KLSE:0203
0.083x
Firefly Neuroscience, Inc.
NASDAQ:AIFF
-0.154x
Wanted Lab Inc.
KQ:376980
0.039x
EG Corporation
KQ:037370
-0.059x
Curis Inc
NASDAQ:CRIS
-0.708x

Annual Cash Flow Conversion Efficiency for Simris Alg AB (publ) (2014–2025)

The table below shows the annual cash flow conversion efficiency of Simris Alg AB (publ) from 2014 to 2025. For the full company profile with market capitalisation and key ratios, see SIMRIS-B company net worth.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 Skr-470.00K
≈ $-50.58K
Skr-16.05 Million
≈ $-1.73 Million
34.138x +1168.91%
2024-12-31 Skr5.64 Million
≈ $607.06K
Skr-18.02 Million
≈ $-1.94 Million
-3.194x -125.03%
2023-12-31 Skr25.61 Million
≈ $2.76 Million
Skr-36.35 Million
≈ $-3.91 Million
-1.419x -79.74%
2022-12-31 Skr23.03 Million
≈ $2.48 Million
Skr-18.19 Million
≈ $-1.96 Million
-0.790x +20.67%
2021-12-31 Skr18.22 Million
≈ $1.96 Million
Skr-18.14 Million
≈ $-1.95 Million
-0.995x -142.26%
2020-12-31 Skr47.42 Million
≈ $5.10 Million
Skr-19.48 Million
≈ $-2.10 Million
-0.411x +16.96%
2019-12-31 Skr35.00 Million
≈ $3.77 Million
Skr-17.32 Million
≈ $-1.86 Million
-0.495x +11.61%
2018-12-31 Skr39.78 Million
≈ $4.28 Million
Skr-22.27 Million
≈ $-2.40 Million
-0.560x -1.15%
2017-12-31 Skr42.68 Million
≈ $4.59 Million
Skr-23.62 Million
≈ $-2.54 Million
-0.553x -93.91%
2016-12-31 Skr65.32 Million
≈ $7.03 Million
Skr-18.64 Million
≈ $-2.01 Million
-0.285x -32.17%
2015-12-31 Skr38.68 Million
≈ $4.16 Million
Skr-8.35 Million
≈ $-898.81K
-0.216x +75.83%
2014-12-31 Skr9.78 Million
≈ $1.05 Million
Skr-8.73 Million
≈ $-939.92K
-0.893x --

About Simris Alg AB (publ)

ST:SIMRIS-B Sweden Biotechnology
Market Cap
$16.63 Million
Skr154.55 Million SEK
Market Cap Rank
#25649 Global
#529 in Sweden
Share Price
Skr0.11
Change (1 day)
-0.43%
52-Week Range
Skr0.04 - Skr0.17
All Time High
Skr14.17
About

Simris Group AB (PUBL), a biotechnology company, develops antibody-drug conjugate (ADC) payloads in Sweden and internationally. The company develops, manufactures, and sells bioactive substances from cultured microalgae and cyanobacteria. It also offers cosmetics and skincare products; biopharmaceuticals; and dietary supplements. The company was incorporated in 2011 and is headquartered in Hammen… Read more